Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

February 14, 2024

The Company will Host a Conference Call and Webcast on February 29, 2024, at 8:30 AM ET

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13% to $14.89 Friday morning.

Why Catalyst Pharmaceuticals Stock Is Trading Lower ↗

January 05, 2024

Via Benzinga

Recap: Catalyst Pharmaceuticals Q3 Earnings ↗

November 08, 2023

Via Benzinga

Jim Cramer Likes This Bank 'Very, Very Much,' Says Stock Is Up 7% Over Past 6 Months ↗

January 22, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Stanley Black & Decker, Inc.

Via Benzinga

Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances ↗

January 18, 2024

With our improving economy, you need to invest in these top biotech stocks that are looking to strike gold this year.

Via InvestorPlace

Topics Economy

3 Biotech Stocks You Can Buy and Hold for the Next Decade ↗

January 15, 2024

These companies are still in the early innings of their growth potential.

Via The Motley Fool

Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 ↗

January 14, 2024

With multiple drugs on the market and revenue ramping up, the sky's the limit.

Via The Motley Fool

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

January 09, 2024

Small-cap stocks tend to outperform mid- and large-cap stocks over time and make for an important component of a balanced portfolio.

3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January ↗

January 08, 2024

Via InvestorPlace

Topics Stocks

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

January 05, 2024

Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

January 05, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday.

Via Benzinga

Topics Stocks

Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

January 04, 2024

Amgen stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 74.

Amgen Stock Sees Relative Strength Rating Improve To 74 ↗

December 29, 2023

On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before.

Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study ↗

December 28, 2023

On Thursday, Ultragenyx Pharm stock received a positive adjustment to its Relative Strength (RS) Rating, from 77 to 81.

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

December 28, 2023

On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before.

Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher ↗

December 26, 2023

So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.

Small Caps Are On A Tear Including Speculative Biotechs ↗

December 26, 2023

Via Talk Markets

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 21, 2023

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Via Benzinga

Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma

December 18, 2023

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

Via InvestorPlace

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies

December 05, 2023

Catalyst Ranked #4 on the List

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

December 04, 2023

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference

November 16, 2023

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

November 08, 2023

The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be.

3 Robinhood Stocks to Buy Right Now ↗

November 05, 2023

Via The Motley Fool

Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®

November 02, 2023

New Patents Further Reinforce the FIRDAPSE® (amifampridine) Intellectual Patent Portfolio

Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo

October 30, 2023